Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs FibroBiologics Inc. (FBLG)

Alzamend Neuro, Inc. and FibroBiologics Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and FibroBiologics Inc. are of similar size ($6.4M and $6.3M). Across the 9 metrics below, Alzamend Neuro, Inc. leads on 9 and FibroBiologics Inc. on 0.

Valuation

Metric ALZN FBLG Biotechnology median
P/E n/m n/m 11.19
P/S n/m n/m 9.15
P/B 1.01 1.31 2.23
Price to free cash flow n/m n/m 26.14
EV/EBITDA 0.16 n/m 0.71
EV/Sales n/m n/m 8.65
Earnings yield (175.57%) (584.21%) (33.82%)
Free cash flow yield (121.76%) (247.37%) (23.58%)

Profitability

Metric ALZN FBLG Biotechnology median
Gross margin 0.00% — 68.27%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.23%) (660.08%) (50.82%)
Return on assets (122.36%) (166.14%) (46.08%)
Return on invested capital 0.00% (932.71%) 0.00%

Growth

Metric ALZN FBLG Biotechnology median
Revenue growth (TTM) — — 7.42%
EPS growth (last fiscal year) 76.77% (23.53%) 29.86%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALZN FBLG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 2.64 4.72
Net debt to EBITDA 0.08 0.31 1.01

Dividend

Metric ALZN FBLG Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ALZN FBLG Biotechnology median
Market cap 6.27m 6.44m 176.65m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack